Banque de Luxembourg Investments (BLI)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.9M Sell
38,931
-16,840
-30% -$9.45M 0.74% 35
2026
Q1
$37.4M Hold
55,771
– – 1.12% 26
2025
Q4
$38M Sell
55,771
-14,052
-20% -$9.57M 1.12% 26
2025
Q3
$44.1M Sell
69,823
-29,077
-29% -$17.6M 1.29% 20
2025
Q2
$52.5M Sell
98,900
-20,500
-17% -$9.8M 1.5% 16
2025
Q1
$49.6M Buy
119,400
+1,000
+0.8% +$434K 1.5% 23
2024
Q4
$48.9M Buy
+118,400
New +$51.9M 1.33% 27

Other funds holding IDXX

Banque de Luxembourg Investments (BLI)'s IDXX Position: Q2 2026 in Review

Banque de Luxembourg Investments (BLI) reduced its Idexx Laboratories (IDXX) stake by 30% in Q2 2026, selling an estimated $9.45M and leaving 38,931 shares worth $20.9M. The position accounts for 0.74% of the portfolio, ranked #35.

Banque de Luxembourg Investments (BLI) first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $52.5M in Q2 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Banque de Luxembourg Investments (BLI) held 38,931 shares of Idexx Laboratories worth $20.9M as of Q2 2026.
  • Banque de Luxembourg Investments (BLI) sold 16,840 Idexx Laboratories shares in Q2 2026, an estimated $9.45M.
  • Idexx Laboratories made up 0.74% of Banque de Luxembourg Investments (BLI)'s portfolio in Q2 2026, its #35 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Banque de Luxembourg Investments (BLI)'s Idexx Laboratories position peaked at $52.5M in Q2 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q2 2026, filed 10 Aug 2026.